A Common Antidepressant Restores Calcium Balance and Extends Mouse Lifespan
Disrupted calcium ion homeostasis drives aging in mice — and rescuing it with a repurposed antidepressant significantly boosted median and maximum lifespan.
Summary
Researchers have discovered that disrupted calcium ion (Ca²⁺) homeostasis is a key feature of aging in both progeroid (accelerated-aging) mice and naturally aging mice. When scientists intervened using a well-known antidepressant drug to restore normal calcium balance inside cells, they observed significant increases in both median and maximum lifespan in the treated animals. Calcium ions regulate critical cellular processes including muscle contraction, gene expression, and cell death pathways. When calcium regulation breaks down with age, it can trigger widespread cellular dysfunction. This study suggests that targeting calcium homeostasis may be a viable longevity strategy, and that an already-approved, widely-used drug could be repurposed to achieve this effect in mammals. The findings open a new mechanistic avenue in aging biology and raise the possibility of near-term translational research in humans.
Detailed Summary
Aging biology has long focused on pathways like mTOR, sirtuins, and senescence, but a new study highlights calcium ion homeostasis as a central and underappreciated driver of the aging process. Disruption of Ca²⁺ signaling has cascading effects on cellular function, and this research demonstrates that restoring it can meaningfully extend lifespan in mice — a finding with significant implications for longevity medicine.
The study examined Ca²⁺ dysregulation in two mouse models: progeroid mice, which carry mutations causing accelerated aging, and naturally aging wild-type mice. In both groups, researchers identified disrupted calcium homeostasis as a shared hallmark, suggesting it is not an artifact of genetic disease but a genuine feature of biological aging.
To rescue calcium balance, the scientists administered a well-known antidepressant — likely a drug already approved for human use — that modulates calcium-related cellular pathways. Treated mice showed statistically significant improvements in both median lifespan and maximum lifespan compared to controls. This dual improvement is notable, as extending maximum lifespan is generally harder to achieve and more indicative of targeting a fundamental aging mechanism.
The implications are potentially broad. Ca²⁺ governs processes including mitochondrial function, autophagy, neuronal signaling, and apoptosis. Chronic dysregulation may accelerate tissue deterioration across multiple organ systems simultaneously. Targeting a single upstream regulator of calcium balance could therefore produce wide-ranging healthspan benefits.
Several important caveats apply. The full paper is not publicly available, limiting detailed analysis of methodology, dosing, and effect sizes. Mouse-to-human translation remains uncertain, and the specific antidepressant has not been named in available materials. Nonetheless, this represents a compelling new mechanistic angle on aging that warrants urgent follow-up in primate models and eventually clinical trials.
Key Findings
- Ca²⁺ homeostasis disruption is a shared aging feature in both progeroid and naturally aging mice.
- Restoring calcium balance with a repurposed antidepressant significantly extended median mouse lifespan.
- Maximum lifespan also increased, suggesting a fundamental aging mechanism is being targeted.
- Calcium dysregulation may serve as a novel, druggable hallmark of aging across species.
- An existing FDA-approved drug class may be repurposable for longevity applications.
Methodology
The study used progeroid mouse models alongside naturally aging wild-type mice to establish calcium dysregulation as a common aging feature. Researchers then administered a well-known antidepressant to rescue Ca²⁺ homeostasis and tracked median and maximum lifespan outcomes in treated versus control animals. Full methodological details including sample sizes, dosing regimens, and statistical analyses are unavailable as the full paper is behind a paywall.
Study Limitations
This summary is based on the abstract only, as the full paper is not open access — key details on methodology, effect sizes, and drug identity are unavailable. Mouse lifespan findings do not automatically translate to humans, and species differences in calcium physiology are significant. The specific antidepressant used has not been publicly identified in available materials, limiting immediate clinical applicability.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: